KRAS and metastatic neoplasm: In contrast to these experimental studies, a clinical study by Modest et al[52] showed that, in comparison to KRAS codon 12-mutated CRC, codon 13-mutated tumors have a more aggressive course, with local and distant metastatic disease presenting at the first diagnosis.